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Patients ≥75 years old presenting with acute myocardial infarction (AMI) have complex
coronary anatomy in part due to prior coronary artery bypass grafting (CABG), percuta-
neous coronary interventions (PCI), calcific and valvular disease. Using the National
Readmission Database from January 2016 to November 2017, we identified hospital
admissions for acute myocardial infarction in patients ≥75 years old and divided them
based on a history of CABG. We evaluated in-hospital outcomes, 30-day mortality, 30-day
readmission and predictors of PCI in cohorts. Out of a total of 296,062 patients ≥75 years
old presenting with an AMI, 42,147 (14%) had history of previous CABG. Most presented
with a non-ST segment elevation myocardial infarction, and those with previous CABG
had higher burden of co-morbidities and were more commonly man. The in-hospital mor-
tality was significantly lower in those with previous CABG (6.7% vs 8.8%, adjusted odds
ratio, 0.88, 95% confidence interval, 0.82 to 0.94). Medical therapy was more common in
those with previous CABG and 30-day readmission rates were seen more frequently in
those with prior CABG. Predictors of not undergoing PCI included previous PCI, female,
older ager groups, heart failure, dementia, malignancy, and higher number of co-morbid-
ities. In conclusion, in patients ≥75 years old with AMI the presence of prior CABG was
associated with lower odds of in-hospital and 30-day mortality, as well as lower complica-
tions rates, and a decreased use of invasive strategies (PCI, CABG, and MCS). However,
30-day MACE readmission was higher in those with previous CABG. © 2020 Elsevier
Inc. All rights reserved. (Am J Cardiol 2020;135:9−16)
TaggedH1Background TaggedEnd
TaggedPAcute cardiovascular disease is a leading cause of mor-
bidity and mortality in adults of any age, however elderly
patients are at a higher risk for adverse outcomes, including
mortality and rehospitalizations.1 With improvement in
revascularization options for both stable and acute coronary
disease and resultant increase life expectancy, elderly
patients presenting with acute myocardial infarction (AMI)
have complex coronary anatomy in part due to previous
coronary artery bypass grafting (CABG), percutaneous cor-
onary interventions (PCI), calcific and valvular disease.1,2
Moreover, aging is also associated with higher rates of non-
cardiac co-morbidities such as renal disease, cognitive dys-
function and polypharmacy which complicates treatment
strategies such as antiplatelet and anticoagulant therapies,
risk of contrast-induced nephropathy and timely discharge.
With this inherent age disparity and less invasive revascu-
larization approach for AMI in elderly patients we sought
to investigate whether preexisting CABG has any impact in
the treatment plan and in hospital outcomes. TaggedEnd
TaggedH1Methods TaggedEnd
TaggedP he study cohort was derived from the National Read-
mission Database (NRD), a publicly available database of
all-payer hospital inpatient stays developed by the Agency
for Healthcare Research and Quality as part of the Health-
care Cost and Utilization Project. The NRD was constructed
from 22 States with reliable and verified patient linkage
numbers in the State Inpatient Databases that could be used
to track the patient across hospitals within a State, while
adhering to strict privacy guidelines. We used the NRD
database from January 2016 to November 2017.TaggedEnd
TaggedP he NRD database includes approximately 14 million
patients and around 2,000 hospitals per year. National esti-
mates are obtained using sampling weights provided.
Patients have a unique identifier, which allows each patient
to be tracked (the variable named “NRD_visitlink”). We
determined the time between the first admission and the
readmission by using the variable “NRD_daystoevent” and
calculating the difference between that variable and the
length of stay. A detailed explanation of all the variables in
the NRD is available online (https://www.hcup-us.ahrq.
gov/nrdoverview.jsp). Institutional Review Board (IRB)
review and approval was not required as the NRD is a
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publicly available database containing de-identified patient
information. TaggedEnd
TaggedP he study population was identified using the Interna-
tional Classification of Diseases, Tenth Edition, Clinical
Modification (ICD-10-CM) diagnostic codes for a primary
discharge diagnosis of acute myocardial infarction (ICD-
10-CM code I21.x) and those ≥75 years old. Patients were
then divided into 2 cohorts based on a previous history of
CABG using the ICD-10-CM diagnostic code of Z95.1
(Presence of aortocoronary bypass graft). The exclusion cri-
teria consisted of patients admitted during the month of
December, as NRD patient tracking is limited to a single
calendar year, (n = 33,093), younger than 75 years old
(n = 810,154), same day admission-transfers (n = 22,943),
out of state patients (n = 21,264), and patients who did not
have mortality data (n = 94) (Figure 1). Baseline character-
istics, such as age, gender, and relevant comorbidities were
collected. The severity of co-morbid conditions was defined
using a validated Deyo modification of Charlson Co-mor-
bidity Index.3,4 Other characteristics such as teaching status
of the hospital, median household income, insurance status,
and discharge disposition were also included. TaggedEnd
TaggedP he primary outcome was in-hospital mortality. Second-
ary outcomes included 30-day mortality, 30-day readmis-
sion rate, 30-day major adverse cardiovascular events
(MACE) readmissions, acute kidney injury (AKI), AKI
requiring dialysis, acute ischemic stroke, acute respiratory
failure, acute liver failure, palliative care consultation,
length of stay, and hospital costs. Thirty-day MACE read-
missions included all patients with a primary readmission
diagnosis of acute coronary syndrome, acute heart failure,
and ventricular tachycardia/fibrillation. Principal etiologies
of readmission were also evaluated for both cohorts. TaggedEnd
TaggedPUnivariate differences in baseline characteristics
between both cohorts were evaluated using Pearson chi-
square tests for categorical variables and Wilcoxon rank-
sum tests for continuous variables. Multivariate linear and
logistic regression were used to compare hospital outcomes
between groups, adjusting for potential confounders, such
as age, gender, type of acute coronary syndrome, hyperten-
sion, diabetes, dyslipidemia, heart failure, previous myocar-
dial infarction (MI), previous PCI, smoker, end stage renal
disease (ESRD), chronic obstructive pulmonary disease
(COPD), dementia, peripheral artery disease (PAD), malig-
nancy, obesity, atrial fibrillation, Do not resuscitate (DNR)
status, Charlson comorbidity index, teaching status, hospital
bed size, and median household income. Statistical analysis
was performed with STATA version 14 (StataCorp, Texas).
A p-value less than 0.05 was considered significant for all
the analyses. TaggedEnd
TaggedH1Results TaggedEnd
TaggedPA total of 296,062 patients ≥75 years old presented with
an acute myocardial infarction, out of which 14%
(N = 42,147) had history of previous CABG. The majority
TaggedEnd TaggedFigure
Figure 1. Flowchart with patient selection. A total of 1,837,611 patients with acute coronary syndrome were identified from 2016 to 2017; among which
373,456 were ≥75 years. After exclusion criteria, 296,062 patients were included in the analysis; 42,147 (14.2%) had a prior CABG and 253,915 didn’t have
a prior CABG. CABG = coronary artery bypass grafting. TaggedEnd
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presented with non-ST segment elevation myocardial
infarction (NSTEMI) (79%), with an even higher frequency
in those with previous CABG (89.2% vs 77.7%, p
<0.001). In patients presenting with ST segment elevation
myocardial infarction (STEMI) (21%), inferior wall
STEMI was most commonly seen (42.9%), followed by
anterior wall MI (32.5%), and 24.6% were located on
another wall or unspecified location of MI. The median
age for those with previous CABG was 82 years and
those without previous CABG had a median age of
83 years old. Patients with previous CABG were more
likely to be male compared wih those without it (69% vs
46.5%, p <0.001) and those with CABG had a higher bur-
den of comorbidities (Table 1). TaggedEnd
TaggedPMost patients underwent medical management irrespec-
tive of the history of CABG (69.2% in those with previous
CABG and 58.1% in those without previous CABG). As
expected, those with previous CABG had lower rates redo
CABG (0.9% vs 5.6%, p <0.001) and interestingly, lower
rates of PCI (30% vs 36.7%, p <0.0001). When patients
were evaluated by type of AMI, those with CABG present-
ing with STEMI had lower rates of PCI (52.2% vs 65.7%, p
<0.001). Among patients presenting with NSTEMI, the




Variable Overall (N = 296,062) YES (N = 42,147) NO (N = 253,915) p Value
Type of myocardial infarction
NSTEMI 79.3% 89.2% 77.7% <0.001
STEMI 20.7% 10.8% 22.3%
Anterior wall 32.5% 17.4% 33.7% <0.001
Inferior wall 42.9% 45.9% 42.7%
Other 24.6% 36.8% 23.6%
Age (median [IQR]) 83 (78-88) 82 (78-87) 83 (78-88) <0.001
Men 49.8% 69.0% 46.5% <0.001
Hypertension 86.3% 91.3% 85.4% <0.001
Diabetes Mellitus 37.6% 48.7% 35.8% <0.001
Heart failure 45.1% 52.9% 43.8% <0.001
Systolic heart failure 25.5% 31.1% 24.6% <0.001
Dyslipidemia 65.8% 77.8% 63.8% <0.001
Prior percutaneous coronary intervention 16.8% 28.2% 14.9% <0.001
Obesity 9.4% 9.8% 9.3% 0.017
Smoker 1.0% 0.8% 1.0% 0.004
Chronic obstructive pulmonary disease 22.8% 22.6% 22.9% 0.427
End Stage Renal Disease 3.1% 4.0% 3.0% <0.001
Peripheral artery disease 15.6% 21.4% 14.7% <0.001
Atrial fibrillation 31.9% 34.7% 31.5% <0.001
Prior implantable cardioverter defibrillator 2.3% 6.0% 1.6% <0.001
Do Not Resuscitate (DNR) Status 20.2% 18.6% 20.5% <0.001
Dementia 16.4% 13.8% 16.8% <0.001
Malignancy 5.3% 5.0% 5.3% 0.044
Charlson Comorbidity Index33 65.8% 76.1% 64.1% <0.001
Other characteristics
Teaching hospital 62.8% 62.5% 62.9% 0.513
Hospital Bed Size
Small 15.5% 15.7% 15.5% 0.686
Medium 29.9% 30.1% 29.9%
Large 54.6% 54.3% 54.7%
Median household income percentile
0 - 25th 27.5% 26.9% 27.5% 0.037
26th - 50th 28.7% 29.6% 28.6%
51st - 75th 25.0% 25.0% 25.0%
76th - 100th 18.8% 18.5% 18.9%
Primary Payer
Medicare 94.3% 94.6% 94.3% <0.001
Medicaid 0.9% 0.6% 1.0%
Private Insurance 3.2% 3.1% 3.3%
Self-pay/ Other 1.6% 1.8% 1.5%
Discharge disposition
Home 71.9% 76.8% 71.0% <0.001
Nursing Home/ Facility 24.6% 19.7% 25.5%
Other 3.5% 3.5% 3.5%
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of PCI and CABG in the cohort of patients with previous
CABG. Patients with previous CABG had less likelihood of
undergoing multivessel PCI. The use of mechanical circula-
tory support, such as Intra-aortic balloon pump (IABP) and
Impella, was lower in those with previous CABG, regard-
less of the type of AMI (Table 2)TaggedEnd
TaggedP he primary outcome, in-hospital mortality, was signifi-
cantly lower in those with previous CABG (6.7% vs 8.8%,
adjusted odds ratio [aOR]: 0.88, 95% confidence interval
[CI] 0.82 to 0.94). When analyzed by type of AMI, those
presenting with STEMI and previous CABG had no signifi-
cant difference in mortality when compared to those with-
out CABG (16.3% vs 16.7%, aOR 0.99 95% CI 0.86 to
1.13); however, those with NSTEMI and previous CABG
had significant lower odds of in-hospital mortality (5.5% vs
6.4%, aOR 0.83, 95% CI 0.76 to 0.90). A subgroup analysis
by age groups (75 to 80 years, 81 to 85 years, and >85
years) demonstrated that those patients in older age groups
with previous CABG had significantly lower mortality than
those without previous CABG (Figure 2).TaggedEnd
TaggedPWhen comparing secondary outcomes between
cohorts, we found those with previous CABG had a
lower rate of 30-day mortality, cardiogenic shock, AKI,
acute ischemic stroke, blood transfusions, acute respira-
tory failure, and acute liver failure. The 30-day MACE
readmission and 30-day all-cause readmission was
higher in those with previous CABG (Figure 3). Hospi-
tal costs were significantly higher in those without pre-
vious CABG (Figure 4). Factors that associated either
with increased or lower odds for PCI during index
admission for AMI are shown in Figure 5. TaggedEnd
TaggedH1Discussion TaggedEnd
TaggedPUsing real-world data, we evaluated a large cohort of
patients ≥ 75 years old who presented with AMI and pro-
vided new insights about the relationship of previous
CABG and in-hospital outcomes (Figure 6). The key find-
ings of our study are (1) despite lower rates revasculariza-
tion, patients with previous CABG had significantly lower
in-hospital mortality. (2) Subgroup analysis demonstrated
lower mortality rates in those older than 80 years old. (3)
Those with previous CABG had lower rates of in-hospital
complication, such as cardiogenic shock, AKI, respiratory
failure, liver failure, acute ischemic stroke, and blood trans-
fusions. (4) Rates of revascularization (PCI or CABG) and
use of MCS were lower in those with previous CABG. (5)
30-day readmission rates for MACE were higher in those
patients with previous CABG, nonetheless, the 30-day mor-
tality was still lower in those with previous CABG. TaggedEnd
TaggedPEven though rates of CABG in the United States have
decreased,5 the prevalence of patients who have had CABG
will remain the same or will increase as the morbidity and
mortality in this patient population improves. Elderly
patients with previous CABG presenting with AMI can rep-
resent a challenge for physicians, as they can present with
atypical symptoms, ECGs may be less diagnostic than in




All AMI Overall (N = 296,062) YES (N = 42,147) NO (N = 253,915) p Value
Coronary Angiogram 55.9% 51.5% 56.6% <0.001
Percutaneous coronary intervention 35.8% 30.0% 36.7% <0.001
Single-vessel PCI 27.7% 23.3% 28.4% <0.001
Multivessel PCI 8.1% 6.7% 8.4% <0.001
Coronary artery bypass grafting 4.9% 0.9% 5.6% <0.001
Medical treatment 59.7% 69.2% 58.1% <0.001
Intra-aortic balloon pump 2.8% 1.2% 3.1% <0.001
Impella 0.8% 0.4% 0.8% <0.001
STEMI Overall (N = 61,185) YES (N = 4,560) NO (N = 56,625) p Value
Coronary Angiogram 74.2% 66.2% 74.9% <0.001
Percutaneous coronary intervention 64.7% 52.2% 65.7% <0.001
Single-vessel PCI 52.5% 40.4% 53.5% <0.001
Multivessel PCI 12.2% 11.7% 12.3% 0.561
Coronary artery bypass grafting 3.7% 0.9% 3.9% <0.001
Medical treatment 32.6% 47.3% 31.4% <0.001
Intra-aortic balloon pump 7.1% 4.5% 7.3% <0.001
Impella 1.4% 0.6% 1.5% <0.001
NSTEMI Overall (N = 234,877) YES (N = 37,587) NO (N = 197,290) p Value
Coronary angiogram 51.1% 49.7% 51.4% 0.002
Percutaneous coronary intervention 28.2% 27.4% 28.4% 0.008
Single-vessel PCI 21.2% 21.2% 21.2% 0.882
Multivessel PCI 7.1% 6.1% 7.3% <0.001
Coronary artery bypass grafting 5.2% 0.9% 6.0% <0.001
Medical treatment 66.7% 71.9% 65.7% <0.001
Intra-aortic balloon pump 1.7% 0.8% 1.8% <0.001
Impella 0.6% 0.4% 0.6% <0.001
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TaggedEnd TaggedFigure
Figure 2. In-hospital mortality. The in-hospital mortality was significantly lower in those with prior CABG. Subgroup analysis showed no significant differ-
ence in mortality in STEMI; however, those with NSTEMI and prior CABG had significant lower mortality. Patients in older age groups with prior CABG
had significantly lower mortality than those without prior CABG. TaggedEnd
TaggedEnd TaggedFigure
Figure 3. Secondary outcomes. Patients with prior CABG had lower rates of 30-day mortality, however, had higher 30-day readmission and 30-day MACE
readmission rates. Lower complications rates were seen in those with prior CABG.TaggedEnd
TaggedEnd TaggedFigure
Figure 4. Total hospital costs for patients with and without prior CABG. The total hospital costs were significantly lower for patients with prior CABG.TaggedEnd
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Figure 5. Predictors of PCI during index admission for AMI. In patients ≥75 years old presenting with acute myocardial infarction, a history of prior CABG,
older age groups, female gender, NSTEMI, heart failure, COPD, dementia, malignancy, DNR status, atrial fibrillation, a Charlson Comorbidity Index >3
were independent predictors of medical management. Predictors of PCI included dyslipidemia, prior MI, peripheral arterial disease, prior PCI, obesity, teach-
ing hospital, medium to large hospital size and a higher median household. AMI = acute myocardial infacrtion; CABG = coronary artery bypass grafting;
PCI = percutaneous coronary intervention. TaggedEndTaggedEnd TaggedFigure
Figure 6. Summary of the study findings. Among patients 75 years and older who presented with an acute myocardial infarction, those with a history of prior
CABG had lower in-hospital and 30-day mortality, as well as lower rates of organ failure, rates of PCI, CABG, MCS use, length of stay and hospital costs
when compared with those without prior CABG.TaggedEnd
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frequently used.6,7 We found lower incidence of STEMI in
those with previous CABG and lower rates of PCI and re-
do CABG (less than 1%). As described by Fosbol et al, the
rates of repeated CABG in older individuals is low and
there is a significant variation between centers. Overall,
there has been a declining rate of re-do CABG over the
years with a steady increase in the rates of PCI.8 A sub-
group analysis in our cohort evaluating mortality in those
who underwent CABG during the index admission,
revealed higher mortality in patients undergoing redo
CABG, although this was not statistically significant
(11.6% vs 6.2%, p = 0.06). A study by Welsh et al revealed
that patients with previous CABG presenting with STEMI
were less likely to undergo revascularization and had a
higher 90-day mortality.9 We reported similar findings
regarding a higher burden of comorbidities and lower revas-
cularization rates in those with previous CABG, however,
we found lower in-hospital and 30-day mortality in those
with previous CABG. Even though in our study the
patients’ age was higher, the 30-day mortality was overall
lower in our cohort with AMI (6.7% for those with previous
CABG and 8.8% in those without previous CABG). The
lower mortality seen in our study highlights the protective
mechanism of CABG; because the grafts bypass the first 7-
cm segment of the coronary artery, which is the most com-
mon segment for new plaque rupture.10 This protective
mechanism of CABG has been described in previous
important trials, such as SYNTAX Trial and BARI Study,
in which the rates of repeated revascularization and/or MI
were higher in patients that underwent PCI at 5 to 10
years.11,12 TaggedEnd
TaggedP he elderly population is typically underrepresented in
randomized control trials; however, the TACTICS-TIMI 18
trial found a reduction of death or MI at 6 months in
patients >75 years old undergoing an invasive versus con-
servative strategy, though, the rates of bleeding were higher
for those undergoing an invasive strategy.13 In our study,
almost 70% of patients with previous CABG underwent a
conservative treatment and around 60% of those without
previous CABG also underwent a conservative approach.
Lower rates of revascularization in those with previous
CABG could potentially explain the increased odds of 30-
day MACE readmission as well as the higher number of
comorbidities. Nonetheless, in those patients with previous
CABG, 8.7% underwent PCI during the readmission com-
pared to 10.9% in those without previous CABG
(p = 0.008). Emphasizing the importance of guideline-
directed medical therapy in the elderly, which is less fre-
quently accomplished when compared with younger
patients.14 Optimal medical therapy benefits preventing
MACE and symptoms in this morbid population,15 in addi-
tion to choosing early invasive strategy when appropriate,
regardless of the age group.16,17 This approach is supported
by the ACC/AHA NSTEMI guidelines which recommend
guideline-directed medical therapy, early invasive strategy
and revascularization as appropriate for patients ≥75 years
old.18 TaggedEnd
TaggedPLastly, we reported predictors favoring PCI versus medi-
cal management in our cohort; factors associated with lower
rates of PCI included previous CABG, older age groups (81
to 85 years and >85 years), female gender, NSTEMI, higher
number of comorbidities, malignancy, DNR status, and
dementia among others. In contrast, predictors of undergo-
ing PCI included previous MI, previous PCI, obesity, PAD,
teaching hospital and larger hospital bed size. Hao et al19
described similar factors associated with not performing
PCI in AMI, including female gender, older age groups,
acute heart failure, and NSTEMI. There are several limita-
tions to the present study. We are not able to identify the
timing of the previous CABG, and neither to differentiate if
the culprit lesion was a native vessel or a graft. Mortality
data does not distinguish between cardiac and non-cardiac
causes of death. In addition, the study is limited to in-hospi-
tal and 30-day outcomes only and long-term outcome data
are not available. The NRD data is based on ICD-10-CM
codes, and like any administrative database, there is a possi-
bility of coding error. Lack of information about laboratory
results, medications, and imaging findings renders a more
comprehensive analysis unfeasible with this database.
Despite these limitations, our results demonstrate robust
findings using real world data of the impact of previous
CABG in the outcomes of patients ≥75 years old presenting
with AMI. TaggedEnd
TaggedPIn conclusion, patients ≥75 years old presenting with
AMI are more frequently treated conservatively than by
revascularization. The presence of previous CABG was
associated with lower odds of in-hospital and 30-day mor-
tality, as well as lower complication rates. Thirty-day
MACE readmission rates were higher in those with previ-
ous CABG, possibly secondary to a combination of higher
co-morbidities and a more frequent use of conservative
management during the index hospitalization. Predictors
for a conservative strategy included previous CABG,
female gender, older ager groups, heart failure, dementia,
malignancy, and higher number of comorbidities. TaggedEnd
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